Answers are grounded in this paper and cite their sources.
Parkinson's disease (PD) presents a challenge, with neuroinflammation and immune dysregulation central to its pathogenesis. This review examines TREM2-a microglial receptor governing phagocytosis, metabolic adaptation, and immune phenotypes-as an important orchestrator of innate immunity across PD, with roles that appear stage- and context-dependent. We synthesize structure, signaling, and heterogeneity; integrate single-cell multi-omics, animal models, and clinical data; outline conserved mechanisms; and consider translational implications as an investigational biomarker and therapeutic target, emphasizing spatiotemporal dynamics.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: